The diagnostics company will open a lab with Corewell Health in 2027 and manage the not-for-profit health system’s existing ...

Quest Diagnostics is launching a new pharmacogenomics program designed to decode patients’ DNA to predict how they will respond to certain therapies and doses. | Quest said its test will span drugs ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that detects and measures the level of PFAS.

Advances in drug treatments for Alzheimer’s disease have opened doors for diagnostics, and Quest is the latest to walk through. The clinical testing giant has put forward a blood test designed ...